CN103083433A - 一种治疗风湿和风湿性坐骨神经痛的药物 - Google Patents
一种治疗风湿和风湿性坐骨神经痛的药物 Download PDFInfo
- Publication number
- CN103083433A CN103083433A CN2013100273606A CN201310027360A CN103083433A CN 103083433 A CN103083433 A CN 103083433A CN 2013100273606 A CN2013100273606 A CN 2013100273606A CN 201310027360 A CN201310027360 A CN 201310027360A CN 103083433 A CN103083433 A CN 103083433A
- Authority
- CN
- China
- Prior art keywords
- medicine
- parts
- treatment
- radix aconiti
- rheumatism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 208000008765 Sciatica Diseases 0.000 title claims abstract description 32
- 229940079593 drug Drugs 0.000 title abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 208000025747 Rheumatic disease Diseases 0.000 claims description 27
- 230000000552 rheumatic effect Effects 0.000 claims description 27
- 241000283690 Bos taurus Species 0.000 claims description 24
- 239000004922 lacquer Substances 0.000 claims description 24
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 19
- 229930006000 Sucrose Natural products 0.000 claims description 19
- 241001611401 Opistophthalmus boehmi Species 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 239000012535 impurity Substances 0.000 claims description 13
- 238000012216 screening Methods 0.000 claims description 13
- 238000005303 weighing Methods 0.000 claims description 13
- 241000131808 Scolopendra Species 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 235000009508 confectionery Nutrition 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 241000239226 Scorpiones Species 0.000 claims description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 3
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 241001180876 Saposhnikovia Species 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 229960004793 sucrose Drugs 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 208000002193 Pain Diseases 0.000 abstract description 20
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000010792 warming Methods 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000522620 Scorpio Species 0.000 abstract 1
- 239000009490 scorpio Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000006820 Arthralgia Diseases 0.000 description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 7
- 230000001617 migratory effect Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 244000052769 pathogen Species 0.000 description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010051728 Bone erosion Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000009921 Rheumatoid Nodule Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 208000001106 Takayasu Arteritis Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 229960001193 diclofenac sodium Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 201000006292 polyarteritis nodosa Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 例数 | 治愈 | 好转 | 无效 | 有效率% |
治疗组 | 90 | 20 | 65 | 5 | 94.4 |
对照组 | 90 | 21 | 63 | 6 | 93.3 |
组别 | 例数 | 治愈 | 好转 | 无效 | 有效率% |
治疗组 | 90 | 21 | 63 | 6 | 93.3 |
对照组 | 90 | 20 | 63 | 7 | 92.2 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310027360.6A CN103083433B (zh) | 2013-01-24 | 2013-01-24 | 一种治疗风湿和风湿性坐骨神经痛的药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310027360.6A CN103083433B (zh) | 2013-01-24 | 2013-01-24 | 一种治疗风湿和风湿性坐骨神经痛的药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103083433A true CN103083433A (zh) | 2013-05-08 |
CN103083433B CN103083433B (zh) | 2015-06-17 |
Family
ID=48196912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310027360.6A Expired - Fee Related CN103083433B (zh) | 2013-01-24 | 2013-01-24 | 一种治疗风湿和风湿性坐骨神经痛的药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103083433B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877500A (zh) * | 2014-03-18 | 2014-06-25 | 张希富 | 一种治疗风寒湿邪所致诸症的药酒 |
CN104435212A (zh) * | 2014-11-05 | 2015-03-25 | 兰柳生 | 一种治疗风湿性关节炎的中药药剂 |
CN104644801A (zh) * | 2014-11-05 | 2015-05-27 | 兰柳生 | 一种治疗坐骨神经痛的中药制剂 |
CN108524718A (zh) * | 2018-07-09 | 2018-09-14 | 杨全胜 | 一种治疗风湿、类风湿及坐骨神经痛的药物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101670011A (zh) * | 2009-06-08 | 2010-03-17 | 潘首德 | 一种治疗风湿、类风湿的药物及其制备方法 |
CN101708232A (zh) * | 2009-12-01 | 2010-05-19 | 李细莲 | 风湿骨痛外用药酒 |
CN102697878A (zh) * | 2012-06-21 | 2012-10-03 | 陈慧婷 | 治疗风湿性关节炎的葛根中药制剂及制备方法 |
-
2013
- 2013-01-24 CN CN201310027360.6A patent/CN103083433B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101670011A (zh) * | 2009-06-08 | 2010-03-17 | 潘首德 | 一种治疗风湿、类风湿的药物及其制备方法 |
CN101708232A (zh) * | 2009-12-01 | 2010-05-19 | 李细莲 | 风湿骨痛外用药酒 |
CN102697878A (zh) * | 2012-06-21 | 2012-10-03 | 陈慧婷 | 治疗风湿性关节炎的葛根中药制剂及制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103877500A (zh) * | 2014-03-18 | 2014-06-25 | 张希富 | 一种治疗风寒湿邪所致诸症的药酒 |
CN104435212A (zh) * | 2014-11-05 | 2015-03-25 | 兰柳生 | 一种治疗风湿性关节炎的中药药剂 |
CN104644801A (zh) * | 2014-11-05 | 2015-05-27 | 兰柳生 | 一种治疗坐骨神经痛的中药制剂 |
CN108524718A (zh) * | 2018-07-09 | 2018-09-14 | 杨全胜 | 一种治疗风湿、类风湿及坐骨神经痛的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN103083433B (zh) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102058673A (zh) | 一种祛风除湿的中药组合物及其制备方法 | |
CN104491052B (zh) | 治疗风湿及类风湿性关节炎的中药组合物及其制备方法 | |
CN103083433B (zh) | 一种治疗风湿和风湿性坐骨神经痛的药物 | |
CN103182019A (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN104000890B (zh) | 调和肝脾、祛风除湿、养血止痹痛的中药 | |
CN102416126A (zh) | 一种治疗白塞氏病的中药组合剂及其制备方法 | |
CN1762454A (zh) | 治疗牛皮癣的中药组合物 | |
CN105456818A (zh) | 一种含有艾叶的治疗失眠的中药组合物及其制备方法 | |
CN104306618A (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN104337989A (zh) | 一种含鹅不食草和乳香的治疗痛风的中药组合物 | |
CN101708286B (zh) | 治疗干燥综合症、顽固性口腔溃疡的中成药及其制法 | |
CN103394002A (zh) | 一种治疗皮肤瘙痒的药物组合物及其制备方法和用途 | |
CN103550615B (zh) | 一种治疗脾肾两虚证型泄泻病的中药 | |
CN103585414B (zh) | 一种治疗坐骨神经痛并骨质疏松症的药物组合物 | |
CN102302604B (zh) | 一种治疗关节炎的中药 | |
CN101028445B (zh) | 一种治疗鱼鳞病的中成药 | |
CN100571725C (zh) | 一种治疗坐骨神经痛的中药制剂 | |
CN104622995A (zh) | 一种治疗慢性浅表性胃炎的药物组合物及其制备方法 | |
CN103933154A (zh) | 一种治疗痛风病的中药组合物及其制备方法 | |
CN103768454A (zh) | 一种具有预防和治疗hiv/aids的组合物及其制备方法 | |
CN103599419B (zh) | 一种治疗痛风的中药组合物 | |
CN107595998B (zh) | 一种用于中风恢复期的中药组合物及其制备方法 | |
CN106853193A (zh) | 一种治疗类风湿性关节炎的中药及其制备方法 | |
CN105148078A (zh) | 一种用于治疗口腔溃疡的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Drug for treating rheumatism and rheumatoid sciatica Effective date of registration: 20170905 Granted publication date: 20150617 Pledgee: Bank of Guiyang, Limited by Share Ltd, Yuping branch Pledgor: Guizhou Dalong Health Grease Co.,Ltd. Registration number: 2017990000823 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180907 Granted publication date: 20150617 Pledgee: Bank of Guiyang, Limited by Share Ltd, Yuping branch Pledgor: Guizhou Dalong Health Grease Co.,Ltd. Registration number: 2017990000823 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Drug for treating rheumatism and rheumatoid sciatica Effective date of registration: 20180917 Granted publication date: 20150617 Pledgee: Bank of Guiyang, Limited by Share Ltd, Yuping branch Pledgor: Guizhou Dalong Health Grease Co.,Ltd. Registration number: 2018520000019 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190905 Granted publication date: 20150617 Pledgee: Bank of Guiyang, Limited by Share Ltd, Yuping branch Pledgor: Guizhou Dalong Health Grease Co.,Ltd. Registration number: 2018520000019 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150617 Termination date: 20200124 |